Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001615774-17-004904
Filing Date
2017-09-01
Accepted
2017-09-01 17:16:00
Documents
3
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A s107398_10ka.htm 10-K/A 362989
2 EX-31.01 s107398_ex31-01.htm EX-31.01 4013
3 EX-31.02 s107398_ex31-02.htm EX-31.02 3819
  Complete submission text file 0001615774-17-004904.txt   371934
Mailing Address 509 MADISON AVE. - SUITE 306 NEW YORK NY 10022
Business Address 509 MADISON AVE. - SUITE 306 NEW YORK NY 10022 1-800-849-7894
Tonix Pharmaceuticals Holding Corp. (Filer) CIK: 0001430306 (see all company filings)

EIN.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-36019 | Film No.: 171066946
SIC: 2834 Pharmaceutical Preparations